Ep5 Lessons From a Second-Time Founder, At the Cutting Edge of MedTech скачать в хорошем качестве

Ep5 Lessons From a Second-Time Founder, At the Cutting Edge of MedTech

In this episode of 7 Questions, Wayne sits down with Scott Murray, a Brisbane-born founder now based in London, to talk through a founder journey that’s been nearly three decades in the making. Scott co-founded his first company back in 1997 and went on to scale it internationally across Asia, the US, and Europe before successfully exiting in 2017. He stayed on for another five years after the acquisition, eventually stepping away in 2022 feeling burnt out, but also carrying a huge amount of hard-earned experience about what it really takes to build and sustain a global business through tough financial periods, pressure, and long growth cycles. But retirement didn’t last long. Scott is now the co-founder and CEO of Aurovian, a MedTech startup developing wearable biosensor technology that can monitor therapeutic drug levels in real time. The first focus is lithium monitoring for bipolar disorder patients, with the goal of enabling more precise, personalised treatment while reducing suicide risk and preventing toxic side effects. Working alongside co-founder Andrew Hazelton and collaborating with King’s College London, Scott is bringing decades of founder experience into what is now a five-year MedTech journey, moving forward one milestone at a time. In this conversation, they talk openly about founder resilience, managing burnout, staying disciplined when scope wants to expand, building the right culture, and why patient capital is essential when you’re working in deep tech. What you’ll learn in this episode ☑️Why building a company that lasts requires sustainability, with the right systems, processes, and culture to get through tough seasons ☑️The reality of founder burnout after decades of pressure, and why stepping back to reset can be critical ☑️Why precision medicine is the future, and how wearable biosensors could transform lithium monitoring for bipolar patients ☑️Why MedTech is a long game, with five-year timelines and milestone-driven progress ☑️One of the hardest founder disciplines: limiting scope while balancing optimism and focus ☑️How culture can become a real competitive advantage in deep tech companies ☑️The pivotal moment when Aarovian proved its biosensor technology worked, unlocking confidence and momentum ☑️How bringing in specialised talent, including PhDs in biochemistry, accelerated the company’s progress ☑️Why founders don’t necessarily love risk, but become comfortable operating in uncertainty ☑️Why Scott is focused on building a long-term company, not just developing IP for a quick exit If you found this conversation valuable, consider sharing it with a founder or operator who might appreciate it too. Connect with Scott Murray: LinkedIn:   / scott-murray-513221   Learn more about Aurovian: Website: https://www.aurovian.com/ LinkedIn:   / aurovian-limited   Watch the full episode and subscribe for more conversations with founders building meaningful companies.